A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: Study design and response rates of the Bristol Helicobacter Project

Controlled Clinical Trials

Volumn 23, Issue 3, 2002, Pages 321-332

  Lane, J Athene ^a   Harvey, Richard F ^b   Murray, Liam J ^c   Harvey, Ian M ^d   Donovan, Jenny L ^a   Nair, Prakash ^e   Egger, Matthias ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Age; Dyspepsia; Gender; Helicobacter pylori; Randomized trial; Response rates; Socioeconomic status

Indexed keywords

CLARITHROMYCIN; RANITIDINE BISMUTH CITRATE;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; POPULATION; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAMPLE SIZE; SCREENING; SOCIAL STATUS; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM; UREA BREATH TEST;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DYSPEPSIA; ENGLAND; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RANITIDINE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 0036275630     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(01)00208-2     Document Type: Article

References (40)

1. Dyspepsia and dyspepsia subgroups: A population-based study
2. Diagnosis and treatment of dyspepsia. A cost-effectiveness analysis
3. Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice
4. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States
5. Helicobacter pylori: Epidemiology and routes of transmission
6. Management of nonulcer dyspepsia
7. Systematic review and economic evaluation Helicobacter pylori eradication treatment for non-ulcer dyspepsia
8. Random-zero sphygmomanometer
9. Qualitative and semi-quantitative value of a modified 13C-urea breath test for identification of Helicobacter pylori infection
10. Development of a postal health status questionnaire to identify people with dyspepsia in the general population
11. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?
12. Effect of Helicobacter pylori eradication therapy on dyspeptic symptoms in primary care
13. Quality of life in duodenal ulcer
14. Validating the SF-36 health survey questionnaire: New outcome measure for primary care (see comments)
15. Prevalence of symptoms of dyspepsia in the community
16. Dyspepsia: A dilemma for doctors?
17. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomized controlled trial. Leeds HELP Study Group
18. The urea breath test for Helicobacter pylori
19. Randomized controlled trials in primary care: Case study (see comments)
20. Raising response rates: Getting to yes (editorial; Comment)
21. Control response proportions in population-based case-control studies in Germany
22. Response rates among control subjects in case-control studies
23. Barriers to participation in randomized controlled trials: A systematic review
24. Deprivation and cause specific morbidity: Evidence from the Somerset and Avon survey of health
25. Commentary: Three decades of the inverse care law
26. The inverse care law
27. Recruitment for controlled clinical trials: Literature summary and annotated bibliography
28. Inaccuracy of FHSA registers: Help from electoral registers
29. Age-sex registers as a screening tool for general practice: Size of the wrong address problem
30. Evaluation of the use of general practice age-sex registers in epidemiological research
31. Threats to applicability of randomized trials: Exclusions and selective participation
32. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status
33. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland
34. Results of Helicobacter pylori screening and eradication in a multi-ethnic community in central England
35. The cohort effect and Helicobacter pylori
36. Do socio-economic status, marital status and occupation influence the prevalence of Helicobacter pylori infection?
37. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults
38. Non-ulcer dyspepsia and peptic ulcer: The distribution in a population and their relation to risk factors